{"version":"1.0","type":"link","title":"Erratum: Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations.","author_name":"Di Federico A 외","author_url":"https://prs-insight.online/author/Di%20Federico%20A","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/99126","thumbnail_width":1200,"thumbnail_height":630}